Lv2
130 积分 2021-07-12 加入
First-line systemic treatment for people with extensive-stage small cell lung cancer: a network meta-analysis
1个月前
已关闭
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
4个月前
已完结
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research
4个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
6个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
6个月前
已完结
Claudin 18.2 as a novel therapeutic target
7个月前
已完结
Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2
7个月前
已完结
皖公网安备34019202002308
